162 related articles for article (PubMed ID: 17687101)
1. Fatal pulmonary Mycobacterium xenopi in a patient with rheumatoid arthritis receiving etanercept.
Maimon N; Brunton J; Chan AK; Marras TK
Thorax; 2007 Aug; 62(8):739-40. PubMed ID: 17687101
[TBL] [Abstract][Full Text] [Related]
2. Fatal streptococcal toxic shock syndrome in a patient with rheumatoid arthritis treated with etanercept.
Uthman I; Husari A; Touma Z; Kanj SS
Rheumatology (Oxford); 2005 Sep; 44(9):1200-1. PubMed ID: 15870144
[No Abstract] [Full Text] [Related]
3. Fatal pulmonary Mycobacterium abscessus infection in a patient using etanercept.
Thomas JE; Taoka CR; Gibbs BT; Fraser SL
Hawaii Med J; 2006 Jan; 65(1):12-5. PubMed ID: 16602610
[TBL] [Abstract][Full Text] [Related]
4. The infectious profiles of anti-tumor necrosis factor agents in a Thai population: a retrospective study a the university-based hospital.
Suwannalai P; Auethavekiat P; Udomsubpayakul U; Janvitayanujit S
Int J Rheum Dis; 2009 Jul; 12(2):118-24. PubMed ID: 20374328
[TBL] [Abstract][Full Text] [Related]
5. Purulent pericarditis in a patient with rheumatoid arthritis treated with etanercept and methotrexate.
Sweet DD; Isac G; Morrison B; Fenwick J; Dhingra V
CJEM; 2007 Jan; 9(1):40-2. PubMed ID: 17391602
[TBL] [Abstract][Full Text] [Related]
6. Mycobacterium mucogenicum: report of a skin infection associated with etanercept.
Shehan JM; Sarma DP
Dermatol Online J; 2008 Jan; 14(1):5. PubMed ID: 18319022
[TBL] [Abstract][Full Text] [Related]
7. Pneumococcal meningitis and etanercept--chance or association?
Killingley B; Carpenter V; Flanagan K; Pasvol G
J Infect; 2005 Aug; 51(2):E49-51. PubMed ID: 16038750
[TBL] [Abstract][Full Text] [Related]
8. Fatal Mycobacterium peregrinum pneumonia in refractory polymyositis treated with infliximab.
Marie I; Heliot P; Roussel F; Hervé F; Muir JF; Levesque H
Rheumatology (Oxford); 2005 Sep; 44(9):1201-2. PubMed ID: 15941728
[No Abstract] [Full Text] [Related]
9. Management of accelerated pulmonary nodulosis following etanercept therapy in a patient with rheumatoid arthritis.
Watson P; Simler N; Screaton N; Lillicrap M
Rheumatology (Oxford); 2008 Jun; 47(6):928-9. PubMed ID: 18385217
[No Abstract] [Full Text] [Related]
10. Disseminated Mycobacterium marinum infection in a patient with rheumatoid arthritis receiving infliximab therapy.
Danko JR; Gilliland WR; Miller RS; Decker CF
Scand J Infect Dis; 2009; 41(4):252-5. PubMed ID: 19266397
[TBL] [Abstract][Full Text] [Related]
11. [Non tuberculous anti-TNF associated opportunistic infections].
Marie I; Guglielmino E
Rev Med Interne; 2010 May; 31(5):353-60. PubMed ID: 20381217
[TBL] [Abstract][Full Text] [Related]
12. [Increased risk of infection with biological immunomodifying antirheumatic agents. Clear guidelines are necessary as shown by case reports].
Söderlin M; Blomkvist C; Dahl P; Forsberg P; Fohlman J
Lakartidningen; 2005 Dec 5-11; 102(49):3794-6, 3799-800. PubMed ID: 16408703
[TBL] [Abstract][Full Text] [Related]
13. Nontuberuclous mycobacterial disease: updated diagnostic criteria for an under-recognized infectious complication of anti-tumor necrosis factor therapy.
Winthrop KL; Daley CL; Griffith D
Nat Clin Pract Rheumatol; 2007 Oct; 3(10):E1. PubMed ID: 17906608
[No Abstract] [Full Text] [Related]
14. Development of leprosy in a patient with rheumatoid arthritis during treatment with etanercept: a case report.
Lluch P; Urruticoechea A; Lluch J; Moll MC; Matos M; Benet JM; Ene L; Cañete JD
Semin Arthritis Rheum; 2012 Oct; 42(2):127-30. PubMed ID: 22542278
[TBL] [Abstract][Full Text] [Related]
15. Septic arthritis due to Listeria monocytogenes in a patient receiving etanercept.
Rachapalli S; O'Daunt S
Arthritis Rheum; 2005 Mar; 52(3):987. PubMed ID: 15751076
[No Abstract] [Full Text] [Related]
16. Listeria monocytogenes infection as a complication of treatment with tumor necrosis factor alpha-neutralizing agents.
Slifman NR; Gershon SK; Lee JH; Edwards ET; Braun MM
Arthritis Rheum; 2003 Feb; 48(2):319-24. PubMed ID: 12571839
[TBL] [Abstract][Full Text] [Related]
17. Mesenteric and splenic cat-scratch disease during etanercept therapy.
Schiffmann A; Pers YM; Lukas C; Combe B; Morel J
Rheumatology (Oxford); 2009 Nov; 48(11):1461-2. PubMed ID: 19690129
[No Abstract] [Full Text] [Related]
18. Treatment with tumour necrosis factor alpha antagonists in patients with rheumatoid arthritis induces anticardiolipin antibodies.
Jonsdottir T; Forslid J; van Vollenhoven A; Harju A; Brannemark S; Klareskog L; van Vollenhoven RF
Ann Rheum Dis; 2004 Sep; 63(9):1075-8. PubMed ID: 15066863
[TBL] [Abstract][Full Text] [Related]
19. Safety of etanercept in patients at high risk for mycobacterial tuberculosis infections.
Aggarwal R; Manadan AM; Poliyedath A; Sequeira W; Block JA
J Rheumatol; 2009 May; 36(5):914-7. PubMed ID: 19332623
[TBL] [Abstract][Full Text] [Related]
20. Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety.
Hyrich KL; Silman AJ; Watson KD; Symmons DP
Ann Rheum Dis; 2004 Dec; 63(12):1538-43. PubMed ID: 15242866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
